[go: up one dir, main page]

DK0661981T3 - Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose - Google Patents

Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose

Info

Publication number
DK0661981T3
DK0661981T3 DK93920624.9T DK93920624T DK0661981T3 DK 0661981 T3 DK0661981 T3 DK 0661981T3 DK 93920624 T DK93920624 T DK 93920624T DK 0661981 T3 DK0661981 T3 DK 0661981T3
Authority
DK
Denmark
Prior art keywords
prevention
derivatives
hyaluronic acid
arterial restenosis
restenosis
Prior art date
Application number
DK93920624.9T
Other languages
Danish (da)
English (en)
Inventor
Samuel Simon Asculai
Rudolf Edgar Falk
Eva Anne Turley
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Application granted granted Critical
Publication of DK0661981T3 publication Critical patent/DK0661981T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93920624.9T 1992-09-25 1993-09-22 Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose DK0661981T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002079205A CA2079205C (en) 1992-09-25 1992-09-25 Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (1)

Publication Number Publication Date
DK0661981T3 true DK0661981T3 (da) 1996-12-23

Family

ID=4150463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920624.9T DK0661981T3 (da) 1992-09-25 1993-09-22 Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose

Country Status (26)

Country Link
EP (1) EP0661981B1 (sk)
JP (1) JP3742955B2 (sk)
CN (1) CN1057908C (sk)
AP (1) AP448A (sk)
AT (1) ATE141054T1 (sk)
AU (1) AU670117B2 (sk)
BR (1) BR9307221A (sk)
CA (1) CA2079205C (sk)
CZ (1) CZ288986B6 (sk)
DE (1) DE69303931T2 (sk)
DK (1) DK0661981T3 (sk)
ES (1) ES2091031T3 (sk)
GR (1) GR3021171T3 (sk)
HK (1) HK35397A (sk)
HU (2) HU227067B1 (sk)
IL (1) IL107087A0 (sk)
IN (1) IN181289B (sk)
MD (1) MD960294A (sk)
MX (1) MX9305887A (sk)
NO (1) NO309457B1 (sk)
NZ (1) NZ255978A (sk)
PL (1) PL308201A1 (sk)
SG (1) SG48845A1 (sk)
SK (1) SK36895A3 (sk)
TW (1) TW271401B (sk)
ZA (1) ZA937068B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE295745T1 (de) * 1997-08-22 2005-06-15 Denki Kagaku Kogyo Kk Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
FR2813791B1 (fr) 2000-09-14 2004-03-12 Lafon Labor Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease

Also Published As

Publication number Publication date
BR9307221A (pt) 1999-07-27
NO951122L (no) 1995-03-23
JPH08506797A (ja) 1996-07-23
CN1057908C (zh) 2000-11-01
NO309457B1 (no) 2001-02-05
NZ255978A (en) 1997-02-24
HUT73637A (en) 1996-08-28
SG48845A1 (en) 1998-05-18
GR3021171T3 (en) 1996-12-31
IN181289B (sk) 1998-05-02
CA2079205C (en) 1998-02-10
AP9300568A0 (en) 1993-10-31
EP0661981A1 (en) 1995-07-12
ES2091031T3 (es) 1996-10-16
HU9500857D0 (en) 1995-05-29
TW271401B (sk) 1996-03-01
AU4812693A (en) 1994-04-26
AP448A (en) 1996-01-18
DE69303931T2 (de) 1997-01-09
HU227067B1 (en) 2010-06-28
MX9305887A (es) 1994-05-31
HK35397A (en) 1997-03-27
CA2079205A1 (en) 1994-03-26
CZ288986B6 (cs) 2001-10-17
SK36895A3 (en) 1997-03-05
CN1092654A (zh) 1994-09-28
NO951122D0 (no) 1995-03-23
JP3742955B2 (ja) 2006-02-08
PL308201A1 (en) 1995-07-24
HU211698A9 (en) 1995-12-28
CZ66295A3 (en) 1996-02-14
ZA937068B (en) 1994-04-18
IL107087A0 (en) 1993-12-28
AU670117B2 (en) 1996-07-04
ATE141054T1 (de) 1996-08-15
DE69303931D1 (de) 1996-09-12
EP0661981B1 (en) 1996-08-07
MD960294A (ro) 1997-10-31

Similar Documents

Publication Publication Date Title
DE69431457D1 (de) Intravaskuläre Stents
DE69309132D1 (de) Instraluminarer Stent
DE69315863D1 (de) Expandierbarer Stent
DE69410072D1 (de) Aufweitbare Stents
DE69320136D1 (de) Verbesserter gallenkatheter
DE69409193D1 (de) Intraluminarer Stent
DE69229751D1 (de) Aufweitbare Stents
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
FI931508L (fi) Blandningsanordning foer blandning av tvao vaetskor med konstant blandningsvolymstroem foer foersoerjning av en pappersmaskins inloppslaoda
FI943231L (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnoksia
NO944838D0 (no) Arabinogalaktanderivater og anvendelser derav
DE69430699D1 (de) Medikamente abgebende stents
DE69218426D1 (de) Erhöhte Gasauflösung
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
DE4394018T1 (de) Blutdruckmeßgerät
NO931400D0 (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
DE69318575D1 (de) Weckeruhr
FI1215U1 (fi) Anlaeggning i samband med styrningen av en vira
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
FI935516L (fi) Foerfarande foer att accelerera haerdning av mineralull impregnerad med melaminbindemedel i en mikrovaogsugn
NO931399D0 (no) Anvendelse av naturstein
KR940018972U (ko) 위생 발판
FI952479L (fi) Stenoosin ehkäisy
NO930947L (no) Cykloalkyl- og heterocyklylsubstituerte imidazolylpropensyrederivate
ITMI930345A1 (it) N-acil-peptidi inibitori delle protein-chinasi